Cambridge, MA · Founded 2024 · Privately Held (backing)
Operator of small molecule therapeutics intended to accelerate transmembrane protein drug discovery. Topo Therapeutics is based in Cambridge, MA and was founded in 2024. It was valued at $138 million at its early-stage round in Dec 2024, the last priced event on record. It has raised $10.6 million across 1 recorded round; the latest was a $10.6 million early-stage round in Dec 2024.
PMV mark · valuation
$137.6M
Oct 2026
Priced at
its early-stage round
Dec 2024
Total raised
$10.6M
Last round
Early Stage VC
Dec 2024
Cap table — not yet on record
Topo Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Topo Therapeutics with a free account
·Watch Topo Therapeutics: the Monday email on marks, rounds and moves
Where does Topo Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Topo Therapeutics's 1 recorded funding rounds.
